Perfil
Jeffrey Landau is Chief Executive Officer & Director at Stipple Bio, Inc. since 2025.
Formerly, Mr. Landau was Chief Business Officer, Senior VP & Head-Strategy at CytomX Therapeutics, Inc. from 2021 to 2025, Vice President-Business Development at Catalyst Biosciences, Inc. from 2016 to 2021, and Director-Corporate Development & Marketing at Threshold Pharmaceuticals, Inc. Education includes undergraduate studies at Virginia Polytechnic Institute & State University and an MBA from Stanford Graduate School of Business.
Cargos activos de Jeffrey Landau
| Empresas | Cargo | Inicio |
|---|---|---|
Stipple Bio Inc.
Stipple Bio Inc. BiotechnologyHealth Technology Operates as biotechnology company | Director Ejecutivo | 01/04/2025 |
Antiguos cargos conocidos de Jeffrey Landau.
| Empresas | Cargo | Fin |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Corporate Officer/Principal | 07/02/2025 |
| CATALYST BIOSCIENCES | Corporate Officer/Principal | 01/03/2021 |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Ventas & Marketing | - |
Formación de Jeffrey Landau.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Catalyst Biosciences, Inc.
Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Stipple Bio Inc.
Stipple Bio Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey Landau
















